Dr Reddy’s Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (Montelukast Sodium) oral granules in the US market, following the approval by the United States Food & Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Oral Granules.
The Singulair Oral Granules brand had US sales of about $61 million for the most recent twelve months ending July 2012 according to IMS Health. The company’s Montelukast Sodium Oral Granules in 4mg are available in unit dosage package of 30. -- CA. Rajesh Desai -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
